SillaJen sillajen.com


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1135)

SillaJen is a clinical-stage biotherapeutics company that focuses on the development and commercialization of oncolytic immunotherapy products for cancer. The Company develops Pexa-Vec, an oncolytic immunotherapy to selectively infect and replicate in cancer cells by exploiting the genetic changes that frequently occur in cancer.

SillaJen is a clinical-stage biotherapeutics company that focuses on the development and commercialization of oncolytic immunotherapy products for cancer. The Company develops Pexa-Vec, an oncolytic immunotherapy to selectively infect and replicate i...Show all

Company (Alive / Active)

Phone: +82(51) 517-7550

Fax:

6F, 252, Geumjeong-ro
Geumjeong-gu
Busan, 46274
South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SillaJen $12M Mar 21, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SillaJen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Medivate PartnersPrivate EquitySeoul, South KoreaPrivate Equity
See all 1 investors

Board Members

There is no Competitors data available for this company. Please select another tab.